you will see
ADXS is cramp with a trial from India. ADXS is buying a Volkswagon, ADRO is Buying Mercades
Zack's ( ADXS )
4-14-15 Today News - ADXS added as most heavily weight in immunotherapy index ( LCINDX )
H.C. Wainwright great analyst, initiated AXDS at $9 and in 2 weeks went to $22
4/7/15 ( CYBR )
The ongoing series of well-publicized cyber attacks on large companies is causing businesses to become more concerned about protecting themselves from this threat. CyberArk ( CYBR ) software aims toverify that system users have access permission and is the only security software that can also take defensive steps against intruders. The advanced IT security company has "massive," growth potential.
great time to get in this one.
how much is it per month to receive fly breaking news, is it worth it, thinking of getting. thanks
Celladon Shares May Have Upside to $70
The developer of gene therapy for heart failure to announce pivotal trial results inMarch or April.
We are initiating coverage of Celladon with a Buy rating and 12-month price target of $70.
The total annual cost of treating heart failure today is $39 billion in the U.S. alone. By virtue of investment in Celladon, a number of pharmaceutical companies have a front row seat to evaluate the significance ofCUPID 2. We anticipate a licensing or a merger and acquisition (M&A) transaction, if results are promising for future success